CEO Geoff Martha said Medtronic would submit its application for urological procedures to the Food and Drug Administration by ...

Medtronic stock was down stock was down today after its third-quarter revenue slightly missed the Wall Street analyst consensus.

The massive robot-making, pacemaker-inventing medtech company Medtronic is facing a financial snag: the humble stapler.

The cardiovascular portfolio grew mid-single-digits, with cardiac ablation solutions reporting 22% growth, driven by the Pulse Field Ablation (PFA) products, Affera and PulseSelect. Management ...

Bogle, Medtronic’s head of medical affairs for digital surgery, also discussed the company’s plans to train surgeons for its ...

Medtronic CEO Geoff Martha told investors in November that the company plans to make a submission to the Food and Drug Administration for its Hugo robot ... livestream system that was recently ...

there is plenty of whitespace here for Medtronic. Second, the healthcare giant is developing a robotic-assisted surgery (RAS) device, the Hugo system. This gadget is currently being tested in the ...

The revenue miss came as sales at Medtronic's Medical Surgical division declined 1.9% to $2.07 billion. The company pointed ...